
About Synapmed Global Private Limited
Data last updated:
Synapmed Global Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the healthtech and medical tech solutions segment of the healthcare sector. It was incorporated on 21 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85100KA2020PTC132944. Its GSTIN is 29AATCA3386R1ZH (Karnataka).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Gargi Kumari (Whole-Time Director) and Jayalakshmi Maduranath.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.06 Cr, a growth of 27% compared to the previous year. For the same year it recorded a net profit of ₹1.19 Cr (net margin 9.1%) and EBITDA of ₹2.02 Cr (EBITDA margin 15.5%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years.
The company has about 72 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: AstaLynx Global.
For more details, the company can be reached via its website astalynx.com.
Company details
Recognitions & Rankings of Synapmed Global
Contact details
Synapmed Global Private Limited's registered office is in Bangalore, Karnataka. Its website is astalynx.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressBrigade Opus, 70/401 5th Floor Kodigehalli Main Road Hebbal, Bangalore, Karnataka, India – 560092
- IndustryHealthcare, HealthTech & Medical Tech Solutions
To see the full contact details of Synapmed Global Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Synapmed Global operates one associated brand: AstaLynx Global. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides pharmacovigilance, regulatory, and tech services to biopharma firms worldwide. | astalynx.com |
Business activity
The main business activity of Synapmed Global is information and communication. In detail, this covers other information & communication service activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| J | Information and communication | J8 | Other information & communication service activities |
To see the full business activity and turnover split of Synapmed Global Private Limited, buy the company report.
Financials of Synapmed Global Private Limited
FY 2025 filings availableSynapmed Global Private Limited reported revenue of ₹13.06 Cr (up 27% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 32% over three years, including 27% growth in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.02 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.19 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.5% | ||||
| Net Profit Margin | 9.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Synapmed Global Private Limited, buy the company report.
Board of directors of Synapmed Global Private Limited
Synapmed Global has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayalakshmi Maduranath | Director | 19 Oct 2023 | 3 Years 1 Months | Current |
| Krishnam Raj Kumar Pagadala | Additional Director | 23 Jan 2026 | 0 Years 9 Months | Current |
| Gaurav Mishra Also directs: Qaurus Consulting India Private Limited | Additional Director | 23 Jan 2026 | 0 Years 9 Months | Current |
| Gargi Kumari Also directs: Kretacx Software Private Limited, Theragenx Private Limited | Whole-Time Director | 01 Apr 2025 | 1 Years 7 Months | Current |
Peer comparison
Synapmed Global Private Limited is compared with the 8 companies closest to it by revenue in the same principal business activity (other information & communication service activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Innovation Endeavors India Private Limited | ₹13.16 Cr (FY 2024) | 24.0% | Bangalore, Karnataka, India | |||
| Raven360 India Private Limited | ₹13.15 Cr (FY 2024) | 19.0% | Chennai, Tamil Nadu, India | |||
| Reet Business Private Limited | ₹13.12 Cr (FY 2025) | 60.0% | Kolkata, West Bengal, India | |||
| Synapmed Global Private Limitedthis company | ₹13.06 Cr (FY 2024) | ₹1.19 Cr | 9.1% | 27.0% | 72 | Bangalore, Karnataka, India |
| Square One Media Solutions Private Limited | ₹13.05 Cr (FY 2025) | 28.0% | Pune, Maharashtra, India | |||
| Frux Technologies Private Limited | ₹13.05 Cr (FY 2024) | 192.0% | New Delhi, Delhi, India | |||
| Trential Technologies Private Limited | ₹12.97 Cr (FY 2025) | 3773.0% | Bengaluru, Karnataka, India | |||
| Xelentix Solutions Private Limited | ₹12.96 Cr (FY 2024) | 36.0% | Delhi, India | |||
| MVD Technologies Private Limited | ₹12.94 Cr (FY 2024) | 7.0% | New Delhi, Delhi, India |
To see the full peer comparison of Synapmed Global Private Limited, buy the company report.
Auditor
Synapmed Global Private Limited is audited by M K DANDEKAR & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M K DANDEKAR & CO | FY 2023 | 000679S |
Shareholding
The shareholding of Synapmed Global Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Synapmed Global Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Synapmed Global Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Synapmed Global Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Synapmed Global Private Limited has a workforce of 72 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 72 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 |
To see the full employee and EPFO history of Synapmed Global Private Limited, buy the company report.
GST
Synapmed Global has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AATCA3386R1ZH | Karnataka | Active | 01 Mar 2020 |
To see the full GST registrations and return filing status of Synapmed Global Private Limited, buy the company report.
Recent activity
Synapmed Global Private Limited has 16 board changes on record since 2020: 10 appointments and 6 cessations. The latest: Gaurav Mishra was appointed as Additional Director on 23 Jan 2026.
7 earlier events are in the company report.
Frequently asked questions
Synapmed Global is an active private limited company based in Bangalore, Karnataka, India. The company works in healthtech and medical tech solutions, within the healthcare industry. It was incorporated on 21 February 2020 (6+ years old) and is registered under CIN U85100KA2020PTC132944.
Synapmed Global has 4 current directors:
- Gargi Kumari - Whole-Time Director
- Jayalakshmi Maduranath - Director
- Krishnam Raj Kumar Pagadala - Additional Director
- Gaurav Mishra - Additional Director
The latest financial statements of Synapmed Global on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Synapmed Global is 29AATCA3386R1ZH, registered in Karnataka.
The CIN (Corporate Identification Number) of Synapmed Global is U85100KA2020PTC132944. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synapmed Global was incorporated on 21 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Synapmed Global by revenue are Innovation Endeavors India Private Limited, Raven360 India Private Limited, Reet Business Private Limited, Square One Media Solutions Private Limited, Frux Technologies Private Limited and 3 more, all in the same principal business activity (other information & communication service activities).
Gaurav Mishra was appointed as Additional Director on 23 Jan 2026. Krishnam Raj Kumar Pagadala was appointed as Additional Director on 23 Jan 2026. Gargi Kumari was appointed as Whole-Time Director on 01 Apr 2025. Synapmed Global has 16 board changes on record in total.
Yes, Synapmed Global is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Synapmed Global can be reached through the website astalynx.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Synapmed Global is at Brigade Opus, 70401 5th Floor Kodigehalli Main Road Hebbal, Bangalore, Karnataka, India – 560092.

